Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage

Starting soon · Not applicable

Conditions studied: Nervous System Diseases, Cerebrovascular Disorders, Cardiovascular Diseases, Vascular Diseases, Hemorrhage, Intracranial Hemorrhages, Cerebral Hemorrhage, Cerebral Hemorrhage, Hypertensive, Stroke, Hemorrhagic Stroke, Intracerebral

In brief

MSU-ICH is a prospective, multicenter, Week-wise-randomized, open-label, blinded-endpoint (PROBE) clinical trial comparing ultra-early prehospital blood pressure lowering delivered by a Mobile Stroke Unit (MSU) with standard Emergency Medical Services (EMS) in patients with spontaneous intracerebral hemorrhage.

Key facts

Study ID

NCT07665827

Run by

Xuanwu Hospital, Beijing

People needed

706

Starts

2026-06-01

Expected to finish

2028-07-01

Last updated by the study team

2026-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History and physical/neurological examination consistent with acute stroke.
• Age ≥18 years;
• Time from symptom onset to enrollment <3 hours (onset defined as last known normal).
• Systolic blood pressure ≥150 mmHg and ≤220 mmHg;
• Pre-stroke modified Rankin Scale (mRS) score ≤2;
• Informed consent obtained from the subject or a legally authorized representative.

You may not qualify if…

• Glasgow Coma Scale (GCS) score ≤5.
• Contraindications to intensive blood pressure lowering, including severe arterial stenosis or high-grade stenotic valvular heart disease.
• Malignant disease or other serious primary illness with a life expectancy of <3 months.
• Current participation in another interventional randomized clinical trial.

Where it is running

• Xuanwu Hospital — Beijing, Beijing Municipality, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.